Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 52

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 52
---
 of the forward-looking statements to conform these statements to actual results.

<div align='center'>USE OF PROCEEDS</div>

We estimate that we will receive net proceeds
from this offering of approximately $4,181,431, based on an assumed public offering price of $2.455 per share and accompanying warrants
(the last reported sale price of the common stock on The Nasdaq Capital Market on July 2, 2025) and assuming the sale of all of the securities
being offered pursuant to this prospectus, after deducting the estimated placement agent fees and estimated offering expenses payable
by us and assuming no exercise of the Warrants being issued in this offering. However, because this is a best-efforts offering and there
is no minimum offering amount required as a condition to the closing of this offering, the actual offering amount, the placement agent’s
fees and net proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth on the cover
page of this prospectus.

We currently intend to use the net proceeds from
this offering for working capital and general corporate purposes.

We will retain broad discretion in the allocation
of the net proceeds from this offering and could utilize the proceeds in ways that do not necessarily improve our results of operations
or enhance the value of our common stock.

Pending application of the net proceeds as described
above, we intend to invest the net proceeds of this offering in a money market or other interest-bearing account. The amounts and timing of our actual expenditures will depend upon numerous factors, including our sales and marketing and commercialization efforts, demand for our products, our operating costs and the other factors described under “ Risk Factors” in this prospectus and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Accordingly, our management will have flexibility in applying the net proceeds from this offering. An investor will not have the opportunity to evaluate the economic, financial or other information on which we base our decisions on how to use the proceeds.

<div align='center'>25

DIVIDEND POLICY</div>

We have not declared any cash dividends since
inception and we do not anticipate paying any dividends in the foreseeable future. Instead, we anticipate that all of our earnings will
be used to provide working capital, to support our operations, and to finance the growth and development of our business. The payment
of dividends is within the discretion of the Board and will depend on our earnings, capital requirements, financial